ZTS
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2024-04-01–present
Board Member
Zoetis Inc. (ZTS)Equibles does not estimate personal net worth.
Get an email with a short summary when Zoetis Inc. publishes a filing, an earnings call transcript or a press release.
Get ZTS alertsGavin D.K. Hattersley is recorded as Board Member at Zoetis Inc. (ZTS) since April 1, 2024. Zoetis Inc. reported in an 8-K filed May 22, 2026 a re-election or new board role (director) for Gavin D.K. Hattersley, on the board since at least 2024, effective May 20, 2026. Zoetis Inc. reported in an 8-K filed April 1, 2024 that Gavin D.K. Hattersley was appointed Board of Directors, effective April 1, 2024. Zoetis Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Zoetis Inc. includes Juan Ramón Alaix (CEO), James (Jay) Saccaro (CFO), James Saccaro (CFO and COO) and 7 others.
“Each of the twelve nominees for director was elected to serve for a one-year term until the 2027 Annual Meeting of Shareholders or until each director's successor has been elected and qualified, or until such director's earlier death, resignation or removal.”
“On April 1, 2024, the Board of Directors (the "Board") of Zoetis Inc. (the “Company”) appointed Gavin D.K. Hattersley to the Board, to serve in such capacity until his successor is appointed or qualified or until his resignation or removal.”
2024-04-01–present
ZTS
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2024-04-01–present